Keyphrases
Nonalcoholic Steatohepatitis
100%
Liver Fibrosis
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Diagnostic Approach
100%
Everyday Practices
100%
Hepatocellular Carcinoma
33%
Lifestyle Modification
33%
Type 2 Diabetes Mellitus (T2DM)
33%
Weight Loss
33%
Liver
33%
Disease Progression
33%
Putative Drug Targets
33%
Associated Complications
33%
High-risk Population
33%
Metabolic Syndrome
33%
Patients at Risk
33%
Poor Prognosis
33%
Chronic Liver Disease
33%
Chronic Inflammatory Diseases
33%
Adult Population
33%
Liver Cirrhosis
33%
Primary Care Setting
33%
Advanced Stage
33%
Early Diagnosis
33%
Inflammatory Process
33%
Liver Function Tests
33%
Obesity-related Hypertension
33%
Hepatology
33%
Increasing Prevalence
33%
Transient Elastography
33%
Progressive Form
33%
Associated Comorbidities
33%
Abdominal Ultrasound
33%
Arterial Hypertension
33%
Disease Screening
33%
Nonalcoholic Fatty Liver Disease Activity Score
33%
Fibrosis-4 (FIB-4)
33%
Pharmaceutical Strategies
33%
Extrahepatic Complications
33%
Long-term Strategy
33%
Non-invasive Scoring System
33%
NALFD
33%
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Liver Fibrosis
42%
Hepatocellular Carcinoma
14%
Prevalence
14%
Disease Exacerbation
14%
Lifestyle Modification
14%
Maturity Onset Diabetes of the Young
14%
Liver Cirrhosis
14%
Serositis
14%
Metabolic Syndrome
14%
Fibrosis
14%
Primary Health Care
14%
Chronic Liver Disease
14%
Early Diagnosis
14%
Liver Function Test
14%
Hepatology
14%
Scoring System
14%
Transient Elastography
14%
Transabdominal Ultrasound
14%
Focused Ion Beam
14%
Population Risk
14%
Comorbidity
14%
Nutrition
14%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Liver Fibrosis
42%
Liver Cell Carcinoma
14%
Inflammation
14%
Prevalence
14%
Disease Exacerbation
14%
Fibrosis
14%
Liver Cirrhosis
14%
Metabolic Syndrome X
14%
Chronic Liver Disease
14%
Focused Ion Beam
14%
Comorbidity
14%
Maturity Onset Diabetes of the Young
14%